Get started

Cvsbuy

CVS Health Corp | CVS | Long at $61.00NYSE:CVS Health Corp will need a revision to its business model in order to survive an ever-changing retail/pharmacy environment. However, with a P/E of 10x, debt-to-equity of less than 1x, growing cash flow, and dividend yield of 4.3%, the stock seems quite undervalued. Perhaps activist investors will soon step in, but if history repeats, there may be a nice bounce ahead as the price consolidates in the GETTEX:50S and low $60s. Thus, near its current price of $61, NYSE:CVS is in a personal buy zone. Target #1 = $66.00 Target #2 = $68.00 Target #3 = $75.00 Target #4 = $79.00
NYSE:CVSLong
by NicksAnalysis
CVS rally or bust!$CVS soars after beating the earnings estimates and got upgrader by few analyst. but the upgrade and good earnings didnt really help to extend it rally this morning. due to the overall market pulling back, making the CVS conolidate and entering a squeeze. $CVS average price move per day is about $1.20 to $2.00+ depending on the market volatility. here's my key level price im looking for entries: Buy call above 90.64 and sell at 91.30+ Buy puts below 89.30 and sell at 88.67 or below make sure to set alerts on those key level so you wont miss the move. and always to take your profits as you see one.
NYSE:CVSShort
by CHRIS_B58
CVS is a good buyfor risk-takers this for you, CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager and Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island. By looking at the company file we got this total assets 12/30/2020 12/30/2019 12/30/2018 12/30/2017 230,7 B 222,4B 196,4B 95,1B Increasing percent from the year before. 3.73% in 2020 13.23 % in 2019 106.51% in 2018 The total debt 85,0B 89,0 B 73,4 B 27,0 B percentage change from the year before -4.49 % in 2020 +21.25 % in 2019 +171.85 % in 20218 --------------------------------------------- Debt percentage from assets 36.86% 40.01% 37.37% 28.39% Net Income 7,57B 7,18 B 6,63 B -0.594 B 6,62 B EBIT 12,64 B 12,67 B 12,03 B 4,02 B 9,33 B Free cash flow 15,19 B 13,43 B 10,39 B 6,83 B 6,09 B Return on Investment 5YA 4.12% for the company 6.44 for the sector Return on Assets 5YA 3.06% for the company 5.83 for the sector 5 Year EPS Growth 5YA 3.33% for the company 16.84 for the sector 5 Year Sales Growth 5YA 11.88% for the company 12.01 for the sector Dividend Yield ANN 2.15% for the company 1.37 for the sector Final view After reviewing the company file, we express our opinion as the assets are continuously increasing so the net income, free cash flow which is a good sign by looking at the 5-year ratios we see the company is growing The dividend ratio is perfect for the shareholders who own the shares for long-term investment. the total debt is fine we can see it increasing but in the long run, I believe It will not be a problem for the company. the company performance Improved with the spread of the pandemic, still, I think the pandemic will increase in the coming period as we see omicron news. CVS is a good buy now
NYSE:CVSLong
by youssefallax